These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36688979)

  • 1. Attenuated niacin response is associated with a subtype of first-episode drug-naïve psychosis characterized as serious negative symptoms.
    Zhang T; Gan R; Zeng J; Ye J; Hu Y; Xu L; Wei Y; Tang X; Li C; Liu H; Chen T; Wang J
    Eur Arch Psychiatry Clin Neurosci; 2023 Dec; 273(8):1725-1736. PubMed ID: 36688979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication of the abnormal niacin response in first episode psychosis measured using laser Doppler flowmeter.
    Gan R; Zhao Y; Wu G; Zeng J; Hu Y; Xu L; Wei Y; Tang X; Liu X; Liu H; Chen T; Wang J; Zhang T
    Asia Pac Psychiatry; 2022 Dec; 14(4):e12516. PubMed ID: 35652467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study.
    Langbein K; Schmidt U; Schack S; Biesel NJ; Rudzok M; Amminger GP; Berger M; Sauer H; Smesny S
    Schizophr Res; 2018 Feb; 192():377-384. PubMed ID: 28602647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Specificity of the Abnormal Niacin Response: A Potential Endophenotype Marker in Schizophrenia.
    Yao JK; Dougherty GG; Gautier CH; Haas GL; Condray R; Kasckow JW; Kisslinger BL; Gurklis JA; Messamore E
    Schizophr Bull; 2016 Mar; 42(2):369-76. PubMed ID: 26371338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Attenuated Niacin Response With Inflammatory Imbalance and Prediction of Conversion to Psychosis From Clinical High-risk Stage.
    Zhang T; Xiao X; Wu H; Zeng J; Ye J; Gao Y; Hu Y; Xu L; Wei Y; Tang X; Liu H; Chen T; Liu X; Li C; Zhou L; Wu X; Wang J
    J Clin Psychiatry; 2023 Jul; 84(5):. PubMed ID: 37471530
    [No Abstract]   [Full Text] [Related]  

  • 6. Association between case management and longitudinal decrease in negative symptoms in patients with first episode psychosis: A 2-year follow-up.
    Pelizza L; Maestri D; Leuci E; Quattrone E; Azzali S; Paulillo G; Pellegrini P
    Early Interv Psychiatry; 2022 Nov; 16(11):1185-1191. PubMed ID: 35086160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis.
    Berger GE; Smesny S; Schäfer MR; Milleit B; Langbein K; Hipler UC; Milleit C; Klier CM; Schlögelhofer M; Holub M; Holzer I; Berk M; McGorry PD; Sauer H; Amminger GP
    PLoS One; 2016; 11(2):e0148429. PubMed ID: 26894921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterising cognitive heterogeneity in individuals at clinical high-risk for psychosis: a cluster analysis with clinical and functional outcome prediction.
    Haining K; Gajwani R; Gross J; Gumley AI; Ince RAA; Lawrie SM; Schultze-Lutter F; Schwannauer M; Uhlhaas PJ
    Eur Arch Psychiatry Clin Neurosci; 2022 Apr; 272(3):437-448. PubMed ID: 34401957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When to initiate antipsychotic treatment for psychotic symptoms: At the premorbid phase or first episode of psychosis?
    Zhang T; Xu L; Wei Y; Tang X; Hu Y; Cui H; Tang Y; Xie B; Li C; Wang J
    Aust N Z J Psychiatry; 2021 Mar; 55(3):314-323. PubMed ID: 33143440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of symptoms before a diagnosis of first episode psychosis: a latent class analysis of UK primary care electronic health records.
    Chen Y; Farooq S; Edwards J; Chew-Graham CA; Shiers D; Frisher M; Hayward R; Sumathipala A; Jordan KP
    BMC Med; 2019 Dec; 17(1):227. PubMed ID: 31801530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential use of the topical niacin skin test in early psychosis -- a combined approach using optical reflection spectroscopy and a descriptive rating scale.
    Smesny S; Berger G; Rosburg T; Riemann S; Riehemann S; McGorry P; Sauer H
    J Psychiatr Res; 2003; 37(3):237-47. PubMed ID: 12650743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential objective marker in first-episode schizophrenia based on abnormal niacin response.
    Hu Y; Xu L; Gan R; Wu G; Tang X; Wei Y; Cui H; Hui L; Tang Y; Li C; Chen T; Wan C; Wang J; Zhang T
    Schizophr Res; 2022 May; 243():405-412. PubMed ID: 34187733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Learning to trust: social feedback normalizes trust behavior in first-episode psychosis and clinical high risk.
    Lemmers-Jansen ILJ; Fett AJ; Hanssen E; Veltman DJ; Krabbendam L
    Psychol Med; 2019 Apr; 49(5):780-790. PubMed ID: 29897026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood trauma, antipsychotic medication, and symptom remission in first-episode psychosis.
    Ottesen A; T V Hegelstad W; Joa I; Opjordsmoen SE; Rund BR; Røssberg JI; Simonsen E; Johannessen JO; Larsen TK; Haahr UH; McGlashan TH; Friis S; Melle I
    Psychol Med; 2023 Apr; 53(6):2399-2408. PubMed ID: 37144963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive clusters in first-episode psychosis: Overlap with healthy controls and relationship to concurrent and prospective symptoms and functioning.
    Uren J; Cotton SM; Killackey E; Saling MM; Allott K
    Neuropsychology; 2017 Oct; 31(7):787-797. PubMed ID: 28368139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Specialised first-episode psychosis services: a systematic review of the literature].
    Skalli L; Nicole L
    Encephale; 2011 May; 37 Suppl 1():S66-76. PubMed ID: 21600336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Pre-onset Subthreshold Psychotic Symptoms With Longitudinal Outcomes During Treatment of a First Episode of Psychosis.
    Rosengard RJ; Malla A; Mustafa S; Iyer SN; Joober R; Bodnar M; Lepage M; Shah JL
    JAMA Psychiatry; 2019 Jan; 76(1):61-70. PubMed ID: 30304442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic-inflammatory status as predictor of clinical outcome at 1-year follow-up in patients with first episode psychosis.
    Nettis MA; Pergola G; Kolliakou A; O'Connor J; Bonaccorso S; David A; Gaughran F; Di Forti M; Murray RM; Marques TR; Blasi G; Bertolino A; Pariante CM; Dazzan P; Mondelli V
    Psychoneuroendocrinology; 2019 Jan; 99():145-153. PubMed ID: 30243054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A machine learning approach on whole blood immunomarkers to identify an inflammation-associated psychosis onset subgroup.
    Enrico P; Delvecchio G; Turtulici N; Aronica R; Pigoni A; Squarcina L; Villa FM; Perlini C; Rossetti MG; Bellani M; Lasalvia A; Bonetto C; Scocco P; D'Agostino A; Torresani S; Imbesi M; Bellini F; Veronese A; Bocchio-Chiavetto L; Gennarelli M; Balestrieri M; Colombo GI; Finardi A; Ruggeri M; Furlan R; Brambilla P;
    Mol Psychiatry; 2023 Mar; 28(3):1190-1200. PubMed ID: 36604602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research findings on Greek forensic patients found not guilty by reason of insanity. A juxtaposition of patients who committed a criminal offense during their first psychotic episode with those who did so later in the course of their illness.
    Markopoulou M; Karakasi V; Garyfallos G; Pavlidis P; Douzenis A
    Int J Law Psychiatry; 2021; 75():101673. PubMed ID: 33517142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.